Purpose. This study aims to review the incidence of in-stent restenosis (ISR), the factors which determine restenosis, and to evaluate the use of various endovascular techniques for the management of ISR following carotid artery stenting (CAS). Methods. Four hundred and seven patients (334 men, mean age 63 years, range 46-86, median 65 years) were treated with CAS between December 2000 and March 2004. Three hundred and seventy-two (89%) patients had at least one ultrasound evaluation performed 6 months after procedure (range 6-40). Recurrent stenosis O80% detected with duplex ultrasound scans were further evaluated by angiography and treated with repeat endovascular procedure. Results. CAS was performed successfully in all cases with a Carotid WallStent (Boston Scientific) using a cerebral protection device (filter). Perioperative complications included four (0.9%) minor and two (0.4%) major strokes these latter two patients died at 5 and 12 days after the operation. No other deaths occurred. A total of 15 carotid arteries (3.6%) in 14 patients had ISR. All ISR were treated with a repeat endovascular procedure: three balloon angioplasty alone, eight angioplasty and secondary stenting, four angioplasty with cutting balloon. Postsurgical restenosis was confirmed to be the only predictive factor for the development of in-stent restenosis (OR 14.5, 95% CI 2.3-113.4, pZ0.005). Endovascular treatment of ISR achieved technical success without periprocedurale complications and the absence of significant restenosis over a median follow up time of 12.4 months (range 3.5-30.7). Conclusion. Our experience with a large cohort of CAS showed an encouragingly low incidence of ISR (3.6%) and successful treatment by repeat endovascular intervention. We recommend attempting all endovascular possibilities before performing stent removal.
Carotid angioplasty and stenting (CAS) is being used widely to treat severe carotid obstructive disease, and it is now accepted as a less invasive technique that provides an alternative for some patients, particularly those with significant comorbidities. [1] [2] [3] [4] [5] The procedure is also an attractive therapeutic option for patients with local anatomical factors that make carotid endarterectomy (CEA) difficult or riskier, i.e. restenosis after earlier surgery, 'hostile neck' after radical surgery and/or radiation therapy, distal internal carotid artery (ICA) lesions and carotid dissections. 6, 7 Although early results from several centres have been encouraging, concerns remain regarding long-term durability of CAS. In-stent restenosis (ISR) in other vascular beds ranges from 1 to 50% in published reports 8 and is the more frequent longterm complication of CAS. [9] [10] [11] [12] We have already reported our initial experience of the incidence of ISR after CAS. 10 In the first 195 CAS procedures, we observed 10 cases of ISR (5.2%). We also identified clinical factors, which determine ISR. The multivariate analysis supported the multifactorial origin of this complication. Our results showed that postsurgical restenosis was the only predictive factor for the development of ISR. Now our experience with CAS procedures has grown significantly, passing from 195 to 418 cases. This new study intends to review the factors determining restenosis, and to evaluate the use of various endovascular techniques for the management of ISR (repeat angioplasty, angioplasty and secondary stenting, angioplasty with cutting balloon).
undergoing CAS for significant de novo or recurrent carotid artery occlusive disease between December 2000 and March 2004. Clinical, laboratory, diagnostic, and operative reports, as well as the hospital and postoperative course of each patient, were stored in a computerized database. Interrogation of the database identified 407 consecutive patients (334 men; range 46-86, median age 65 years) who underwent CAS, which represented 29.5% of the 1416 carotid procedures. The aetiology of the 418 lesions (11 bilateral treated in staged procedures) was de novo stenosis in 230 (55.1%) and postsurgical restenosis in 188 (44.9%). The indications for primary stenting were: significant medical comorbid conditions, such as coronary artery disease requiring angioplasty or bypass grafting that had not or could not be revascularized, history of congestive heart failure, current ejection fraction 30% or less, steroid-dependent chronic obstructive pulmonary disease, or measured 1-s forced expiratory volume 30% or less; primary lesions anatomically inaccessible at surgery; previous ipsilateral cervical radiation therapy. A large number of patients were symptomatic (301, 72.8%). The majority of the procedures (411, 98.4%) were elective, and seven (1.6%) were urgent. All procedures were performed using a cerebral protection device (FilterWire EX-Boston Scientific in 386 cases, 92.1%). Plaque echogenicity as assessed by B-mode ultrasound (3500 HDI Philips Medical System/ATL S.p.A.-Bothell, USA) has been found to reliably predict the content of soft tissue and the amount of calcification in carotid plaques. Plaque morphology in terms of echogenicity, defined as reflection of the emitted ultrasound signal, was assessed in a modified version of the classification proposed by Gray-Weale et al. and graded from 1 to 4 as echolucent, predominantly echolucent, predominantly echogenic, or echogenic.
Carotid stent protocol
Our carotid stent protocol is described in Journal of Endovascular Therapy: vol. 10, No. 6, pp. 1031-1038.
Follow-up protocol and criteria for restenosis assessment All patients were followed at the hospital's outpatient clinic at 1, 3, 6 and 12 months after the procedure and every 6 months thereafter. During these routine postoperative visits, the surgeon examined each patient, and a carotid duplex scan was performed. If any change in neurological status was found, either a brain CT or MRI was performed. Exact information about clinical events was obtained in all patients. The diagnosis and quantification of restenosis was performed noninvasively using color-coded duplex ultrasonography; in the majority of cases, an intracranial Doppler flow study was also performed. Velocity criteria used to identify individual categories of restenosis are based on a modification of the University of Washington criteria (according to parameters of Lal et al.
12 ): peak systolic velocity (PSV) less than 130 cm/s, 0-39%; PSV 130-210 cm/s, 40-59%; PSV 210-300 cm/s with end-diastolic velocity less than 120 cm/s, 60-79%; PSV greater than 300 cm/s and end-diastolic velocity greater than 120 cm/s, or internal carotid to common carotid artery systolic velocity ratio greater than 3.2, 80-99%. Clinically significant recurrent stenosis was defined as any ISR of 80% or greater.
Statistical analysis
Data sets were analyzed using univariate methods with the goal of determining the risk factors correlated to the development of ISR. Variables that were believed to have an impact on ISR in the carotid arteries included age, sex, smoking, chronic obstructive pulmonary disease, hypertension, diabetes mellitus, hypercholesterolemia (O200 mg/ml), unstable angina, stable coronary artery disease, chronic heart failure, abdominal aortic aneurysm, peripheral arterial disease, malignancy or autoimmune disease, ISR in other vascular districts, symptomatic stenosis, postsurgical carotid restenosis, CCA intimal thickness, carotid plaque type, long-term pre-CAS antiplatelet therapy, creatinine level O1.3 g/l, baseline vessel diameter, vessel diameter after stenting, postoperative fever, and postoperative white blood cell count ( Table  1 ). The StatXact statistical package (Cytel Software Corporation, Cambridge, MA, USA) was used. A twotailed permutation test was performed to test differences among continuous variables. The Fisher exact test was used to test categorical variables. Cox proportional analysis was used to determine independent predictors of in-stent restenosis; a probability of %0.10 was used to enter variables into the Cox model in a forward-stepwise manner. A probability %0.15 was used to remove variables from the model. Independent predictor variables that contributed to the final multivariate model were considered significant risk factors for restenosis if p%0.05. Continuous data are presented as the meanGSD. The nonparametric Wilcoxon rank sum test was used for group comparisons, while nominal data were analyzed with the chi-square test; p!0.05 indicated a significant difference. To evaluate the fate of the CAS procedure, Kaplan-Meier survival analyses were generated for overall survival, freedom from neurological events, and freedom from ISR.
Results
In all cases, a Carotid WallStent Monorail (Boston Scientific) was successfully deployed, with previous placement of a FilterWire EX (Boston Scientific) to prevent cerebral emboli. Overall perioperative complications included four (0.9%) minor strokes, and two (0.6%) major strokes (one intracranial haemorrhage and one hemispheric stroke); these latter two patients died at 5 and 12 days after the operation. No other deaths occurred. One of the minor stroke patients underwent successful urgent surgical treatment for instent thrombosis. The median duration of surveillance for all 405 survivors was 21 months (absolute range 0-39.1). Five other deaths, all nonprocedure-related, occurred at 42, 44, 60, 111 and 126 days, yielding an overall mortality rate of 1.7% (7/407) for the entire series. The Kaplan-Meier survival analysis (Fig. 1) for the entire series yielded a 97.6% survival rate (95% CI 93.2-98.9%).
During follow-up, nine additional neurological events (two major strokes and seven transient ischemic attacks) were observed; five events were ipsilateral to the treatment site. None of the neurological events occurred in patients with restenosis. The freedom from neurological events, minor stroke and major stroke, (Fig. 2) was 90.2% at 39 months. Fourteen patients, for a total of 15 carotid axes (15/418, 3.6%) had ISR, in one case the restenosis was bilateral. Double (tandem) ISR was found in two cases. The segments affected by restenosis were three proximal ends (common carotid artery), six distal ends (internal carotid artery) and six middle segments of the stent. The ISR in two cases were moderate (50-79%) and in 11 severe (O80%). Five patients were symptomatic and nine asymptomatic. In the two cases of moderate ISR, re-intervention was recommended because of the presence of accompanying contra-lateral occlusion. The cumulative rate of freedom from restenosis was 93.1% at 39 months (Fig. 3) .
All ISRs were treated with a further endovascular procedure: three repeat balloon angioplasty (rBA); eight repeat angioplasty and secondary stenting (rCAS); four angioplasty with cutting balloon (CB). All the procedures were performed using a cerebral protection device (FilterWire EX-Boston Scientific). The first 10 cases of ISR were treated with rBA, utilising conventional balloon. A residual stenosis O 30% required a secondary stenting in seven cases. In the last five cases of ISR, the procedures were successfully performed with a CB using low inflation pressures. Only in one case a residual stenosis required an additional stent (Fig. 4) . No procedurerelated complication occurred within 30 days after any treatment for ISR.
Each patient was strictly followed up with US scanning at 1, 3, 6, 9, 12 months and every 6 months thereafter. Table 2 shows the mean follow-up interval, the % of restenosis-calculated by geometric criteria (comparison of the least transverse diameter at the stenosis with the reference distal internal carotid artery), the median peak systolic velocity (PSV) in the internal carotid artery (ICA), and the mean internal carotid to common carotid PSV ratio for each group of ISR treated with rBA or rCAS or CB. No significant statistical difference was noted between the three groups for each parameter of restenosis (pO0.1). All patients remained asymptomatic and without recurrent restenosis greater than 30% over a median follow-up of 12.4 months (range 3.5-30.7). The multivariate analysis of factors determining restenosis confirm the multifactorial origin of the condition as already reported in our previous study. Postsurgical carotid restenosis in association with postoperative fever (OR 5.3), the need for carotid predilation (OR 3.9), or concomitant malignancy or autoimmune disease (OR 3.4) are key predictors for development of ISR (Table 3) .
Discussion
The long-term outcome after CEA has been welldocumented in several studies; 13 however, despite several thousand CAS procedures reported in the literature, the long-term incidence of ISR remains illdefined. In addition, the high incidence of recurrent stenosis after coronary stenting 14 and femoro-iliac angioplasty with stenting 15 has prompted several clinicians to question the durability of the CAS procedure. In-stent recurrent stenosis after carotid artery stenting has been reported as a relatively infrequent complication by some authors, with an incidence of 3.5-4.9% published. [1] [2] [3] On the contrary other authors stated that carotid ISR is common and unpredictable, reporting a prevalence of restenosis O 21% at 18 months. 11, 16 Our experience with a large cohort of patients (418 CAS followed for a median 21 months) showed an encouragingly low incidence of ISR (3.6%). The multivariate analysis of factors determining restenosis confirms the results previously reported from our initial experience: patients who develop restenosis after surgical endarterectomy are also prone to develop restenosis after CAS. Surgical removal of a stent has not been required in this series; however, some authors suggest that standard CEA with removal of the stent appear to be feasible. 17, 18 We preferred to avoid surgical stent removal in all cases. The patients who undergo CAS are generally at high risk for surgical intervention, particularly if that have postsurgical restenosis. The surgical exposure of the carotid artery in patients, who have undergone CAS, can be particularly complicated because of scarring and the need to access the artery proximal and distal to the stent. Our study demonstrates that ISR can be managed successfully with further endovascular procedures. A repeat angioplasty with a conventional or cutting balloon was always the first solution proposed. When we observed a suboptimal response to dilatation with a residual stenosis O30%, a further stent was placed to obtain a satisfactory result.
Although in the early phase of our experience with the management of carotid ISR we often had to place a second stent, and although at the moment in literature there are not sufficient data to evaluate rBA vs rCAS, we think that is better to avoid an additional stent. In our series, all carotid ISR treated with rCAS at US follow-up showed a kink or bend in the distal ICA and a major hyperplastic reaction at the distal end of the second stent. The application of another stent distally to first one, can change the anatomy of the ICA, resulting in an even sharper bend at the end of the new stent. Consequently, one edge of the stent is projecting into the vessel lumen, whereas the other edge touches the vessel wall and can stimulate a hyperplasia reaction. 19 In our experience, the requirement for additional stent implantation was significantly lower using a cutting balloon (1/5, 20%), compared with a conventional balloon (7/10, 70%). The microsurgical blades of the CB cut directly into the stenotic lesion and disrupt the fibroelastic continuity of the ring of myointimal hyperplasia. These incisions facilitate the maximum extrusion of the neointimal plaque, separated into three or four quadrants. Consequently, the recoil tension is reduced compared to the diffuse hoop stress produced by conventional angioplasty. Angioplasty with CB for the treatment of coronary ISR was demonstrated to have some procedural advantages, such as the use of fewer balloons, less requirement for additional stents, and a lower incidence of balloon slippage. 20 Our initial practice with CB to treat carotid ISR is encouraging both in term of high procedural success rates, significantly lower need for supplementary stenting, low peri-procedural complication rates, and low in-stent restenosis. This study was a retrospective analysis of prospectively gathered data in the context of a nonrandomized design. The small number of observations of ISR represents a potential limitation and consequently restricts the information provided by the study. The small number of observations influenced the wide confidence intervals associated with the odd ratios obtained from Cox regression analysis.
Although the current approach to the treatment of ISR is relatively simple and safe with an endovascular procedure, newer, more aggressive approaches are currently at the investigational level and include intravascular brachytherapy, antiproliferative therapy with drug-coated stents used in other vascular beds, and biodegradable stents. In the absence of evidence for these techniques, we think that the best management of ISR is by repeat endovascular angioplasty, and we recommend attempting all intraluminal possibilities (rBA, rCAS or CB) before performing stent removal.
